ROBIN ERWIN: Open Payments
NPI 1619217171 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,344 in 109 payments from 35 companies in 2025. Trend: 2023 $2,336 · 2024 $2,208 · 2025 $2,344
Food & beverage: $2,344
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $315 |
| Novartis Pharmaceuticals Corporation | 13 | $289 |
| Genentech USA, Inc. | 8 | $167 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| E.R. Squibb & Sons, L.L.C. | 6 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| PFIZER INC. | 5 | $92 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Incyte Corporation | 3 | $72 |
Products named: OPDIVO, ENHERTU, TALVEY, LUTATHERA, RYBREVANT, TECVAYLI, PLUVICTO, IMFINZI.
Industry payments across AL — which companies pay providers there.
